SLC1A5 and cancer: Microarray data pointed to elevated expression levels of SLC1A5 (ASCT2) and SLC7A5 (LAT1) in many cancers (Fuchs and Bode, 2005), which since has been confirmed in many studies and cell lines (reviewed in Bhutia et al., 2015).